tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

BCAB Stock Latest News

BCAB Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Pre-EarningsBCAB Earnings Report this Week: Is It a Buy, Ahead of Earnings?
6d ago
BCAB
BioAtla Awards Executive Bonuses and Stock Units
PremiumCompany Announcements
BioAtla Awards Executive Bonuses and Stock Units
10d ago
8K
BCAB
BioAtla Secures $9.2M for Clinical Program Advancements
PremiumCompany Announcements
BioAtla Secures $9.2M for Clinical Program Advancements
3M ago
8K
BCAB
BioAtla Highlights Advancements in CAB Cancer Therapy
PremiumCompany Announcements
BioAtla Highlights Advancements in CAB Cancer Therapy
3M ago
8K
BCAB
BioAtla to sell 9.68M shares at 95.2c in registered direct offering
PremiumThe Fly
BioAtla to sell 9.68M shares at 95.2c in registered direct offering
3M ago
BCAB
BioAtla presents data on mecbotamab vedotin in advanced NSCLC
PremiumThe FlyBioAtla presents data on mecbotamab vedotin in advanced NSCLC
3M ago
BCAB
Michael Burry Boosts His Bet on Chinese Stocks in Q3
Premium
Market News
Michael Burry Boosts His Bet on Chinese Stocks in Q3
4M ago
JD
HPP
BioAtla downgraded to Neutral from Buy at H.C. Wainwright
Premium
The Fly
BioAtla downgraded to Neutral from Buy at H.C. Wainwright
4M ago
BCAB
BioAtla Reports Q3 2024 Financial Results and Clinical Advances
PremiumCompany Announcements
BioAtla Reports Q3 2024 Financial Results and Clinical Advances
5M ago
BCAB
BioAtla reports Q3 EPS (22c), consensus (36c)
PremiumThe Fly
BioAtla reports Q3 EPS (22c), consensus (36c)
5M ago
BCAB
BioAtla, Context Therapeutics enter exclusive license agreement for BA3362
PremiumThe Fly
BioAtla, Context Therapeutics enter exclusive license agreement for BA3362
6M ago
BCAB
CNTX
BioAtla presented poster of Phase 2 trial data at ESMO meeting
PremiumThe Fly
BioAtla presented poster of Phase 2 trial data at ESMO meeting
6M ago
BCAB
BioAtla rallies after Burry’s Scion discloses new stake
PremiumThe FlyBioAtla rallies after Burry’s Scion discloses new stake
7M ago
BCAB
BioAtla management to meet virtually with BTIG
Premium
The Fly
BioAtla management to meet virtually with BTIG
8M ago
BCAB
These 2 “Strong Buy” Penny Stocks Are Poised for a Big Rally, Say Analysts
Premium
Stock Analysis & Ideas
These 2 “Strong Buy” Penny Stocks Are Poised for a Big Rally, Say Analysts
8M ago
BCAB
CRMD
BioAtla to hold an analyst research and development day
PremiumThe Fly
BioAtla to hold an analyst research and development day
8M ago
BCAB
BioAtla granted FDA FTD for ozuriftamab vedotin
PremiumThe Fly
BioAtla granted FDA FTD for ozuriftamab vedotin
8M ago
BCAB
BioAtla price target lowered to $5 from $12 at JMP Securities
PremiumThe Fly
BioAtla price target lowered to $5 from $12 at JMP Securities
10M ago
BCAB
BioAtla reports Q1 EPS (48c), consensus (79c)
PremiumThe Fly
BioAtla reports Q1 EPS (48c), consensus (79c)
10M ago
BCAB
BCAB Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsBCAB Upcoming Earnings Report: What to Expect?
11M ago
BCAB
BioAtla announces FDA clearance of IND for BA3361
Premium
The Fly
BioAtla announces FDA clearance of IND for BA3361
11M ago
BCAB
BioAtla price target lowered to $7 from $10 at H.C. Wainwright
Premium
The Fly
BioAtla price target lowered to $7 from $10 at H.C. Wainwright
12M ago
BCAB

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >